Gender- and age-adjusted prevalence rates for adenoma (green) and advanced adenoma/carcinoma (red) among screening participants (Scr), patients with fecal occult blood (Mic), patients with macroscopic bleeding (Mac), patients undergoing adenoma surveillance (Ad), patients undergoing carcinoma follow-up (Ca), and patients with other clinical signs and symptoms (Cs)